Artificial intelligence is rapidly inventing new drugs for diseases from Parkinson's disease and antibiotic-resistant superbugs to rare lung conditions.
New research shows an AI-driven liquid biopsy analyzing genome-wide cfDNA fragment patterns can detect early liver fibrosis & cirrhosis and may signal broader chronic disease burden.
As AI systems continue to scale and process nodes shrink further, SDC will only become more prevalent. The OCP whitepaper makes clear that traditional approaches to mitigating SDC are insufficient for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results